H19 and urinary bladder carcinoma: The double promoter construct H19-DTA-P4-DTA exhibited far superior efficiency in vitro (Figure 3), in lysing human bladder carcinoma cell lines, relative to each of the single promoter constructs carrying either DTA DNA sequence alone (H19-DTA or P4-DTA).